Temidol 100 mg is a premium oral alkylating agent primarily used in clinical oncology. Containing the active pharmaceutical ingredient Temozolomide (100 mg), this systemic medication is manufactured to stringent international quality standards. It serves as a frontline therapeutic option for specific malignant brain tumors, offering critical support to healthcare systems, clinical institutions, and bulk buyers worldwide

.

As an established global gateway for specialized pharmaceuticals, Ernest Oncology (a division of the Group of Ernest Pharmaceutical Pvt. Ltd.) provides wholesale export, bulk supply, and streamlined distribution networks to ensure unhindered access to this essential oncology treatment across international markets.

Technical Product Specifications

Clinical Mechanism of Action

The therapeutic efficacy of Temidol 100 mg revolves around its specific ability to disrupt the cellular replication cycle of malignant cells:

• Pro-Drug Conversion: Temozolomide is a pro-drug. At physiological pH levels within the bloodstream and cellular environment, it undergoes rapid, non-enzymatic chemical conversion into its active cytotoxic metabolite, MTIC (monomethyl triazeno imidazole carboxamide).

• DNA Alkylation (Methylation): The active form, MTIC, functions as a powerful methylating agent. It primarily targets and transfers methyl groups to the DNA structure of rapidly dividing cells, specifically sticking to the  positions of guanine residues.

• Induction of Apoptosis: This structural alteration damages the tumor cell's DNA blueprint. When the cell attempts to replicate, standard mismatch repair (MMR) enzymes fail to correct the altered sequence properly. This creates extensive DNA double-strand breaks, overwhelming the cell's repair mechanisms, halting the cell cycle at the phase, and triggering apoptosis (programmed cell death).

Primary Therapeutic Indications

Temidol 100 mg is globally sought after for the clinical management of highly aggressive brain tumors:

• Newly Diagnosed Glioblastoma Multiforme (GBM): Administered in adult patients concomitantly (simultaneously) alongside focal radiotherapy, followed by consecutive cycles of monotherapy.

• Refractory Anaplastic Astrocytoma: Utilized in adult and pediatric patients (aged 3 years and older) who exhibit disease progression or recurrence after undergoing standard initial surgical or radiotherapeutic interventions.

Side Effects & Adverse Reactions

Therapy involving Temidol 100 mg must be closely supervised by clinical oncologists. Potential side effects range from standard gastrointestinal discomfort to severe systemic suppression:

Very Common Side Effects (Occurring in more than 10% of patients)

• Gastrointestinal Distress: Moderate to severe nausea, vomiting, constipation, and diarrhea. (Antiemetic therapies are standardly prescribed before administration).

• Systemic Fatigue: Profound tiredness, asthenia (weakness), and persistent headaches.

• Hematological Suppression: Decreased appetite, potential hair loss (alopecia), and mild skin rashes.

Serious Adverse Risks (Require Immediate Clinical Intervention)

• Severe Myelosuppression: A drastic drop in blood cell counts, resulting in Neutropenia (low white blood cells increasing life-threatening infection risks) and Thrombocytopenia (low blood platelets increasing the risk of uncontrolled bruising or bleeding).

• Hepatotoxicity: Elevation of liver enzymes that can lead to hepatic impairment or failure. Routine Liver Function Tests (LFTs) are mandatory.

• Pneumocystis jirovecii Pneumonia (PCP): An opportunistic lung infection. Patients undergoing long-term concomitant therapy with radiation require prophylactic antibiotic cover.

Administration & Storage Guidelines

Method of Administration

• Temidol 100 mg must be swallowed whole with a full glass of water. It should never be crushed, chewed, or opened.

• To maximize bioavailability and minimize severe nausea, the medication must be taken in a fasting state—either 1 hour before breakfast or at least 2 hours after a meal.

Storage Conditions

• Store at controlled room temperature below 25°C (77°F).

• Keep the product in its original moisture-resistant institutional packaging to shield it from ambient humidity and direct sunlight.

• Keep strictly out of reach of children and pets. Damaged or expired tablets must be handled and disposed of following hazardous biomedical waste protocols.